‘Idea Man’ Paul Allen leaves behind plan to unscramble human immunology

"You have a certain number of dreams in your life that you want to fulfill," Microsoft co-founder Paul Allen said in a 2011 interview discussing his plans to launch cargo, and eventually, people into orbit. Now one of his other dreams — to decode the immune system — has been set in motion, a few months following his death in October.

On Wednesday, his non-profit medical research entity Allen Institute, which already houses divisions dedicated to brain and cellular science, revealed that the late philanthropist had set aside $125 million for an immunology unit to decrypt the delicate balancing act the human immune system plays in health and in sickness.

In order to read this article, you must be an Endpoints News subscriber. (It's free to subscribe.)

← Go back

We produce two daily email newsletters designed to give you a complete picture of what's important in biopharma. It's free to subscribe and never any spam. Join 51,100+ biopharma executives who read Endpoints News every day.

Access is subject to the terms in our Privacy Policy.

The best place to read Endpoints News? In your inbox.

Comprehensive daily news report for those who discover, develop, and market drugs. Join 51,100+ biopharma pros who read Endpoints News by email every day.

Free Subscription

VP Oncology Biology
Skyhawk Therapeutics Waltham, MA
Research Scientist - Immunology
Recursion Pharmaceuticals Salt Lake City, UT

Visit Endpoints Careers ->